Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis

Download Formats

• Thumbnail
  JPEG, 72x14, 15.7 KB
• Preview
  JPEG, 144x27, 18.0 KB
• Low Resolution
  JPEG, 300x57, 24.8 KB
• High Resolution
  JPEG, 1379x260, 67.7 KB

Share This Graphic